Target intelligence / Profile preview

B3GAT1 divergent transcript (B3GAT1-DT)

Target
B3GAT1-DT
Molecular classification
Other (non-coding RNA; lncRNA)
01

Overview

B3GAT1 divergent transcript (B3GAT1-DT) is a long non-coding RNA gene located near the B3GAT1 locus, listed as LOC283177, and is also known as AP004608.1[3][4]. It belongs to the lncRNA subclass and may be involved in regulation through divergent transcription mechanisms, but there is no evidence for protein-coding function, receptor status, or classic molecular target classification[3][5]. Disease association is limited; it has been referenced in the context of prostate cancer[3]. No drugs, mechanisms of action, or biomarkers are recorded for this transcript, and its biological role remains unclear, representing a possible regulatory element rather than a classic druggable target. Divergent transcription per se is a process linked with gene regulation and origination of novel genes but does not entail receptor or enzyme activity[5]. Key distinctions: - B3GAT1-DT is not the protein-coding B3GAT1 enzyme[1]; the latter is a glucuronyltransferase and is a molecular target. - B3GAT1-DT is an RNA transcript, not known to encode any protein or receptor. - Information on function and significance is very limited. If a therapeutic target is required, consult entries for the protein-coding gene B3GAT1 ("Beta-1,3-glucuronyltransferase 1")[1], not its divergent lncRNA transcript.

Other names
LOC283177AP004608.1B3GAT1 divergent transcriptB3GAT1-DT
02

Biological functions

Other (possible regulatory roles; detailed functional information is lacking)
03

Disease associations

Prostate cancer
04

Safety considerations

None describedlncRNAs generally present challenges for therapeutic modulation, such as delivery and specificity

Beyond the preview

Go deeper on B3GAT1 divergent transcript (B3GAT1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B3GAT1 divergent transcript (B3GAT1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call